Patent details

EP2857386 Title: Tigecycline crystalline forms and processes for preparation thereof

Basic Information

Publication number:
EP2857386
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP141853622
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Tigecycline crystalline forms and processes for preparation thereof
French Title of Invention:
Formes cristallines de tigécycline et leurs procédés de préparation
German Title of Invention:
Kristalline Tigecylinformen und Verfahren zur Herstellung davon
SPC Number:

Dates

Filing date:
24/04/2007
Grant date:
22/02/2017
EP Publication Date:
08/04/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/02/2017
EP B1 Publication Date:
22/02/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/04/2017
Expiration date:
24/04/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/02/2017
 
 

Name:
Teva Pharmaceutical Industries Ltd
Address:
5 Basel Street PO Box 3190, 49131 Petah Tiqva, Israel (IL)

Inventor

1

Name:
Levi, Sigalit
Address:
Israel (IL)

2

Name:
Aronhime, Judith
Address:
Israel (IL)

3

Name:
Tsiperman, Evgeny
Address:
Israel (IL)

4

Name:
Koltai, Tamas
Address:
Israel (IL)

Priority

1

Priority Number:
794763 P
Priority Date:
24/04/2006
Priority Country:
United States (US)

2

Priority Number:
796800 P
Priority Date:
01/05/2006
Priority Country:
United States (US)

Classification

IPC classification:
C07C 231/24; C07C 237/26;

Publication

European Patent Bulletin

Issue number:
201708
Publication date:
22/02/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
13/09/2017 Outgoing Correspondence 1